GKV Capital Management Co. Inc. Takes $1.11 Million Position in UnitedHealth Group Incorporated $UNH

GKV Capital Management Co. Inc. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, HoldingsChannel.com reports. The firm bought 4,110 shares of the healthcare conglomerate’s stock, valued at approximately $1,112,000.

A number of other hedge funds also recently made changes to their positions in the business. Essential Partners LLC lifted its holdings in shares of UnitedHealth Group by 7.7% during the 1st quarter. Essential Partners LLC now owns 433 shares of the healthcare conglomerate’s stock worth $117,000 after acquiring an additional 31 shares during the period. J. Derek Lewis & Associates Inc. raised its position in UnitedHealth Group by 12.5% in the first quarter. J. Derek Lewis & Associates Inc. now owns 1,732 shares of the healthcare conglomerate’s stock worth $442,000 after purchasing an additional 193 shares in the last quarter. Groupe la Francaise boosted its holdings in UnitedHealth Group by 13.6% during the first quarter. Groupe la Francaise now owns 17,354 shares of the healthcare conglomerate’s stock valued at $4,696,000 after purchasing an additional 2,077 shares in the last quarter. Western Wealth Management LLC grew its stake in shares of UnitedHealth Group by 61.3% in the 1st quarter. Western Wealth Management LLC now owns 13,769 shares of the healthcare conglomerate’s stock valued at $3,726,000 after purchasing an additional 5,232 shares during the period. Finally, Silicon Valley Capital Partners lifted its position in shares of UnitedHealth Group by 1,605.9% during the 1st quarter. Silicon Valley Capital Partners now owns 34,271 shares of the healthcare conglomerate’s stock worth $9,273,000 after buying an additional 32,262 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on UNH. Royal Bank Of Canada increased their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Barclays upped their target price on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a report on Monday, July 20th. Wells Fargo & Company lifted their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Robert W. Baird raised shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $287.00 to $453.00 in a research note on Thursday, July 16th. Finally, HC Wainwright set a $492.00 target price on UnitedHealth Group in a report on Wednesday, May 27th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $455.92.

UnitedHealth Group Stock Down 1.6%

NYSE:UNH opened at $414.82 on Friday. The stock’s fifty day moving average price is $411.39 and its two-hundred day moving average price is $348.26. The company has a market cap of $376.72 billion, a price-to-earnings ratio of 26.69, a P/E/G ratio of 1.46 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.80 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 19.71 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were paid a $2.32 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. UnitedHealth Group’s payout ratio is 59.72%.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts at Zacks Research raised EPS forecasts for several future periods, including Q3 2026, Q1 2027, Q3 2027, Q4 2027, and Q1 2028. Zacks maintained a “Strong Buy” rating, reinforcing expectations for an earnings recovery.
• Positive Sentiment: Erste Group Bank increased its FY2026 EPS estimate to $19.85 from $18.33 and its FY2027 estimate to $22.44 from $20.87, maintaining a “Buy” rating. MarketBeat UnitedHealth analyst estimates
• Positive Sentiment: Recent coverage highlights UNH’s second-quarter earnings beat, lower medical-cost ratio, improved margins, and raised 2026 guidance as evidence that the company’s turnaround is gaining traction. Its diversified Optum platform and growing use of artificial intelligence are also viewed as longer-term strengths. UnitedHealth turnaround signal
• Positive Sentiment: A separate valuation update lifted the estimated fair value from $424.23 to $475.23, reflecting improved Medicare Advantage and Optum Health assumptions. The average brokerage recommendation remains equivalent to “Buy,” although the usefulness of broadly positive analyst ratings is questioned. UnitedHealth fair value update
• Neutral Sentiment: Commentary says the recent stock advance reflects a Medicare Advantage repricing strategy that management outlined months earlier, suggesting the market is reassessing earnings power rather than responding to a new operational announcement. UnitedHealth Medicare Advantage repricing analysis
• Negative Sentiment: Zacks reduced its Q4 2026 EPS estimate to $2.25 from $2.47 and trimmed its Q2 2028 forecast to $5.84 from $5.92. These isolated cuts may be contributing to caution even as the firm remains bullish overall.
• Negative Sentiment: UnitedHealth faces scrutiny over surprise-billing dispute costs, while broader risks include commercial-market trends, Medicaid exposure, and regulation. Medicare Advantage insurers are also redesigning 2027 plans, potentially affecting enrollment, benefits, and member retention. Cigna and UnitedHealth cost coverage

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.